Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
MedAdvisor Limited ( (AU:MDR) ) has provided an announcement.
MedAdvisor Limited announced the results of its Annual General Meeting, where all resolutions except the adoption of the FY25 Remuneration Report were passed by the requisite majority. The rejection of the Remuneration Report marks a ‘first strike’ under the Corporations Act 2001, indicating potential shareholder dissatisfaction. This outcome could influence future governance and compensation strategies, impacting stakeholder relations and company operations.
The most recent analyst rating on (AU:MDR) stock is a Hold with a A$0.10 price target. To see the full list of analyst forecasts on MedAdvisor Limited stock, see the AU:MDR Stock Forecast page.
More about MedAdvisor Limited
MedAdvisor Solutions (ASX: MDR) is a leader in pharmacy-driven patient engagement solutions, offering personalized experiences to simplify the patient medication journey. The company utilizes THRiV, a cloud-based, AI-enabled platform to enhance pharmacy workflows and patient engagement. MedAdvisor Solutions collaborates with over 34,000 pharmacies across the US, reaching over two-thirds of the population.
Average Trading Volume: 1,465,632
Technical Sentiment Signal: Sell
Current Market Cap: A$12.69M
For a thorough assessment of MDR stock, go to TipRanks’ Stock Analysis page.